Luteolin was first separated from plants of the Reseda genus in 1859. Restricted by technical conditions, it was merely preserved as a phytochemical specimen for a long time afterwards. With advances in molecular biology, the value of luteolin has been gradually uncovered. Its unique molecular structure endows it with favorable bioavailability. Moreover, it can cross the blood-brain barrier and act on multiple target pathways in the human body.

Modern pharmacological studies show that luteolin exerts multiple mechanisms of action: it inhibits the NFκB pathway, down-regulates pro-inflammatory factors and alleviates chronic inflammation in the body; activates the internal antioxidant pathways, scavenges free radicals and reduces oxidative damage; modulates signaling pathways related to cell proliferation and apoptosis, and intervenes in abnormally proliferating cells.

Cellular and animal experiments demonstrate extensive research potential of this substance: it shows auxiliary research value in tumor-related studies; it can protect neurons and deliver potential benefits for cognitive health. Meanwhile, relevant scientific research supports its applications in cardiovascular care, immune regulation and anti-allergy fields.

Notice: Most biological functions of luteolin are currently limited to cellular and animal experiments and have not been fully verified by human clinical trials. It serves as a research raw material and cannot replace medicines for disease treatment. As the natural health raw material track continues to expand, luteolin is expected to become a promising ingredient worthy of attention in the nutrition and wellness industry.